NANOTECH CORP
10KSB, 1997-06-19
BLANK CHECKS
Previous: NANOTECH CORP, 10QSB, 1997-06-19
Next: NANOTECH CORP, 10QSB, 1997-06-19



                                        SECURITIES AND EXCHANGE COMMISSION
                                              WASHINGTON, D.C. 20549

                                                    FORM 10-KSB

[x]     Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange
 Act of 1934 [Fee Required]

For the fiscal year ended March 31, 1995

[ ]     Transition Report Pursuant to Section 13 or 15(d) of the Securities 
Exchange Act of 1934 [No Fee Required]

For the transition period from                          to

Commission file number 0-24368

                                                 NANOTECH CORPORATION
                           Exact name of small business issuer in its charter)

                         DELAWARE                                     33-061175
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer 
                                                       Identification No.)

                 1500 Quail Street, Suite 550
                 Newport Beach, California                                92660
           (Address of principal executive offices)                   (Zip Code)

Registrant's telephone number, including area code:               (714) 660-1500
                                                             -------------------

Securities registered pursuant to Section 12(b) of the Act:              None
                                                             ----------------

Securities registered pursuant to Section 12(g) of the Act: 
 Common Stock, par value $.001
                                                          
           Indicate  by check  mark  whether  the  registrant  (1) has filed all
reports  required to be filed by Section 13 or 15(d) of the Securities  Exchange
Act of 1934 during the preceding 12 months (or for such shorter  period that the
registrant  was required to file such  reports) and (2) has been subject to such
filing requirements for the past 90 days.
                                                      YES   X        NO

           Check if there is no disclosure  of delinquent  filers in response to
Item 405 of Regulation S-B is not contained in this form, and no disclosure will
be contained,  to the best of  registrant's  knowledge,  in definitive  proxy or
information  statements  incorporated by reference in part III of this Form 10-K
or any amendment to this Form 10-K. [ X ]

           State issuer's revenues for its most recent fiscal year: None

           The aggregate market value of the voting stock held by non-affiliates
of the  registrant  as of March 31, 1995 was not  determinable  since the Common
Stock was not traded.

           The number of shares  outstanding  of the issuer's  classes of Common
Stock as of March 31, 1995:

Common Stock, $.001 Par Value - 424,600 shares

                                    DOCUMENTS INCORPORATED BY REFERENCE:  NONE


<PAGE>



                                                      PART I

Item 1.   DESCRIPTION OF BUSINESS

Background

 Picometrix,  Inc., a Delaware  corporation  (the "Company") was incorporated on
June 11, 1992.  The Company has no operating  history other than  organizational
matters,  and was formed  specifically  to be a "clean public shell" and for the
purpose of either merging with or acquiring an operating  company with operating
history and assets.  The  Securities  and  Exchange  Commission  has defined and
designated  these  types  of  companies  as  "blind  pools"  and  "blank  check"
companies.

 The primary  activity of the Company will involve seeking merger or acquisition
candidates  with  whom it can  either  merge or  acquire.  The  Company  has not
selected  any  company  for  acquisition  or merger and does not intend to limit
potential acquisition  candidates to any particular field or industry,  but does
retain the right to limit acquisition or merger candidates, if it so chooses, to
a particular field or industry.  The Company's plans are in the conceptual stage
only.

 The executive  offices of the Company are located at 1500 Quail  Street,  Suite
550, Newport Beach, California 92660. Its telephone number is (714) 660-1500.

Plan of Operation - General

 The Company was  organized  for the purpose of creating a corporate  vehicle to
seek,  investigate and, if such investigation  warrants,  acquire an interest in
one or more  business  opportunities  presented to it by persons or firms who or
which desire to seek the perceived advantages of a publicly held corporation. At
this  time,the  Company  has no  plan,  proposal,  agreement,  understanding  or
arrangement to acquire or merge with any specific  business or company,  and the
Company has not  identified any specific  business or company for  investigation
and  evaluation.  No member of Management or promotor of the Company has had any
material  discussions  with any other company with respect to any acquisition of
that  company.  Although the  Company's  Common  Stock is  currently  not freely
tradeable,  it will  eventually  become  so  under  exemptions  such as Rule 144
promulgated  under the Securities Act of 1933. See  "Description of Securities."
The Company will not restrict its search to any specific  business,  industry or
geographical  location, and the Company may participate in a business venture of
virtually any kind or nature. The discussion of the proposed business under this
caption and throughout this Registration  Statement is purposefully  general and
is not meant to be restrictive of the Company's virtually  unlimited  discretion
to search for and enter into potential business opportunities.

 The  Company  intends  to obtain  funds in one or more  private  placements  to
finance the operation of any acquired business. Persons purchasing securities in
these placements and other  shareholders will likely not have the opportunity to
participate in the decision relating to any acquisition.  The Company's proposed
business is sometimes  referred to as a "blind pool" because any investors  will
entrust their investment  monies to the Company's  management before they have a
chance  to  analyze  any   ultimate  use  to  which  their  money  may  be  put.
Consequently,  the  Company's  potential  success  is heavily  dependent  on the
Company's  management,   which  will  have  virtually  unlimited  discretion  in
searching for and entering into a business opportunity. None of the officers and
directors of the Company has had any experience in the proposed  business of the
Company.  There can be no  assurance  that the Company will be able to raise any
funds in private placements.  In any private placement,  management may purchase
shares  on the same  terms as  offered  in the  private  placement.  (See  "Risk
Factors" and "Management").

 Management  anticipates that it will only participate in one potential business
venture. This lack of diversification should be considered a substantial risk in
investing  in the  Company  because  it will not  permit  the  Company to offset
potential  losses  from one  venture  against  gains  from  another  (see  "Risk
Factors").

 The Company  may seek a business  opportunity  with a firm which only  recently
commenced  operations,  or a developing  company in need of additional funds for
expansion  into new products or markets,  or seeking to develop a new product or
service,  or an  established  business  which may be  experiencing  financial or
operating  difficulties  and is in the  need  for  additional  capital  which is
perceived to be easier to raise by a public company.

                                                         2

<PAGE>



In some instances,  a business opportunity may involve the acquisition or merger
with a corporation  which does not need  substantial  additional  cash but which
desires to establish a public trading  market for its common stock.  The Company
may purchase assets and establish wholly owned  subsidiaries in various business
or purchase existing businesses as subsidiaries.

 The Company  anticipates that the selection of a business  opportunity in which
to participate will be complex and extremely risky.  Because of general economic
conditions,  rapid  technological  advances being made in some  industries,  and
shortages  of available  capital,  management  believes  that there are numerous
firms  seeking the benefits of a publicly  traded  corporation.  Such  perceived
benefits of a publicly traded corporation may include  facilitating or improving
the  terms  on  which  additional  equity  financing  may be  sought,  providing
liquidity  for the  principals  of a  business,  creating a means for  providing
incentive  stock  options  or  similar  benefits  to  key  employees,  providing
liquidity (subject to restrictions of applicable statutes) for all shareholders,
and other factors.  Potentially  available  business  opportunities may occur in
many different  industries and at various  stages of  development,  all of which
will make the task of  comparative  investigation  and analysis of such business
opportunities extremely difficult and complex.

 As is  customary  in the  industry,  the  Company  may pay a  finder's  fee for
locating an acquisition  prospect.  If any such fee is paid, it will be approved
by the Company's  Board of Directors and will be in accordance with the industry
standards.  Such  fees  are  customarily  between  1% and 5% of the  size of the
transaction,  based upon a sliding scale of the amount  involved.  Such fees are
typically in the range of 5% on a $1,000,000 transaction ratably down to 1% in a
$4,000,000 transaction. Management has adopted a policy that such a finder's fee
or real estate  brokerage fee could,  in certain  circumstances,  be paid to any
employee,  officer,  director or 5% shareholder  of the Company,  if such person
plays a material role in bringing a transaction to the Company.

 As part of any transaction, the acquired company may require that Management or
other  stockholders  of the Company sell all or a portion of their shares to the
acquired  company,  or  to  the  principals  of  the  acquired  company.  It  is
anticipated  that the sales  price of such shares will be lower than the current
market price or  anticipated  market price of the Company's  Common  Stock.  The
Company's  funds are not expected to be used for purposes of any stock  purchase
from insiders.  The Company shareholders will not be provided the opportunity to
approve or consent to such  sale.  The  opportunity  to sell all or a portion of
their  shares in  connection  with an  acquisition  may  influence  management's
decision to enter into a specific transaction. However, management believes that
since the  anticipated  sales  price will be less than  market  value,  that the
potential  of a stock  sale by  management  will be a  material  factor on their
decision to enter a specific transaction.

 The above  description of potential sales of management stock is not based upon
any corporate bylaw, shareholder or board resolution,  or contract or agreement.
No other  payments of cash or property are expected to be received by Management
in connection with any acquisition.

 The Company has not formulated  any policy  regarding the use of consultants or
outside advisors,  but does not anticipate that it will use the services of such
persons.

 The Company has, and will continue to have,  insufficient capital with which to
provide the owners of business  opportunities with any significant cash or other
assets.  However,  management believes the Company will offer owners of business
opportunities the opportunity to acquire a controlling  ownership  interest in a
public company at substantially less cost than is required to conduct an initial
public offering.  The owners of the business  opportunities will, however, incur
significant post-merger or acquisition registration costs in the event they wish
to register a portion of their shares for subsequent sale. The Company will also
incur  significant legal and accounting costs in connection with the acquisition
of a  business  opportunity  including  the  costs of  preparing  post-effective
amendments,   Forms  8-K,   agreements   and  related   reports  and   documents
nevertheless,  the  officers and  directors  of the Company  have not  conducted
market  research and are not aware of  statistical  data which would support the
perceived  benefits of a merger or acquisition  transaction  for the owners of a
business opportunity.

 The  Company  does not  intend to make any loans to any  prospective  merger or
acquisition candidates or to unaffiliated third parties.

                                                         3

<PAGE>




Sources of Opportunities

 The Company  anticipates that business  opportunities for possible  acquisition
will be referred by various  sources,  including  its  officers  and  directors,
professional advisers, securities broker-dealers,  venture capitalists,  members
of the financial community, and others who may present unsolicited proposals.

 The Company will seek a potential business  opportunity from all known sources,
but will rely principally on personal  contacts of its officers and directors as
well as indirect  associations  between them and other business and professional
people.   It  is  not  presently   anticipated  that  the  Company  will  engage
professional firms specializing in business acquisitions or reorganizations.

 The  officers  and  directors  of the Company are  currently  employed in other
positions  and will  devote only a portion of their time (not more than one hour
per  week)  to the  business  affairs  of the  Company,  until  such  time as an
acquisition  has been  determined  to be highly  favorable,  at which  time they
expect to spend full time in  investigating  and closing any  acquisition  for a
period of two weeks.  In addition,  in the face of  competing  demands for their
time, the officers and directors may grant priority to their full-time positions
rather than to the Company.

Evaluation of Opportunities

 The analysis of new business  opportunities  will be undertaken by or under the
supervision  of the  officers and  directors of the Company (see  "Management").
Management   intends  to  concentrate  on   identifying   prospective   business
opportunities which may be brought to its attention through present associations
with management.  In analyzing  prospective business  opportunities,  management
will consider such matters as the available technical,  financial and managerial
resources;  working  capital  and  other  financial  requirements;   history  of
operation,  if any; prospects for the future;  present and expected competition;
the quality and experience of management services which may be available and the
depth of that  management;  the potential for further  research,  development or
exploration;  specific  risk factors not now  foreseeable  but which then may be
anticipated to impact the proposed activities of the Company;  the potential for
growth or expansion;  the potential for profit; the perceived public recognition
or acceptance of products,  services or trades; name  identification;  and other
relevant  factors.  Officers and directors of each Company will meet  personally
with   management  and  key  personnel  of  the  firm  sponsoring  the  business
opportunity as part of their investigation.  To the extent possible, the Company
intends to utilize  written reports and personal  investigation  to evaluate the
above factors.  The Company will not acquire or merge with any company for which
audited financial statements cannot be obtained.

 It may be anticipated  that any  opportunity in which the Company  participates
will present certain risks. Many of these risks cannot be adequately  identified
prior to selection of the specific opportunity,  and the Company's  shareholders
must,  therefore,  depend on the ability of  management to identify and evaluate
such risk. In the case of some of the opportunities available to the Company, it
may be  anticipated  that the  promoters  thereof  have been unable to develop a
going concern or that such business is in its  development  stage in that it has
not generated  significant revenues from its principal business activities prior
to the  Company's  participation.  There is a risk,  even  after  the  Company's
participation  in the  activity  and the related  expenditure  of the  Company's
funds,  that the  combined  enterprises  will  still be unable to become a going
concern or advance beyond the development  stage.  Many of the opportunities may
involve new and untested products, processes, or market strategies which may not
succeed.  Such  risks  will  be  assumed  by the  Company  and,  therefore,  its
shareholders.

 The Company will not restrict its search for any specific kind of business, but
may acquire a venture which is in its preliminary or development stage, which is
already in operation,  or in essentially  any stage of its corporate life. It is
currently  impossible to predict the status of any business in which the Company
may become  engaged,  in that such  business may need  additional  capital,  may
merely desire to have its shares  publicly  traded,  or may seek other perceived
advantages which the Company may offer.

Acquisition of Opportunities

 In implementing a structure for a particular business acquisition, the Company
 may become a party to a

                                                         4

<PAGE>



merger,  consolidation,  reorganization,  joint venture,  franchise or licensing
agreement  with another  corporation  or entity.  It may also purchase  stock or
assets of an existing  business.  On the  consummation  of a transaction,  it is
possible that the present management and shareholders of the Company will not be
in control of the  Company.  In  addition,  a majority  or all of the  Company's
officers and directors may, as part of the terms of the acquisition transaction,
resign and be  replaced  by new  officers  and  directors  without a vote of the
Company's shareholders.

 It is anticipated that any securities issued in any such  reorganization  would
be issued in reliance on exemptions from registration  under applicable  Federal
and state  securities  laws.  In some  circumstances,  however,  as a negotiated
element of this  transaction,  the Company may agree to register such securities
either at the time the transaction is consummated,  under certain conditions, or
at specified time thereafter.  The issuance of substantial additional securities
and their  potential  sale into any  trading  market  which may  develop  in the
Company's  Common Stock may have a depressive  effect on such market.  While the
actual  terms of a  transaction  to which the Company  may be a party  cannot be
predicted,  it may be expected that the parties to the business transaction will
find it desirable to avoid the creation of a taxable event and thereby structure
the  acquisition  in  a so  called  "tax  free"  reorganization  under  Sections
368(a)(1) or 351 of the Internal  Revenue Code of 1986, as amended (the "Code").
In order to obtain tax free  treatment  under the Code,  it may be necessary for
the owners of the  acquired  business to own 80% or more of the voting  stock of
the surviving entity. In such event, the shareholders of the Company,  including
investors  in this  offering,  would  retain  less  than 20% of the  issued  and
outstanding  shares of the surviving  entity,  which could result in significant
dilution in the equity of such shareholders.

 As part of the Company's  investigation,  officers and directors of the Company
will meet personally  with  management and key personnel,  may visit and inspect
material  facilities,  obtain  independent  analysis or  verification of certain
information provided,  check reference of management and key personnel, and take
other reasonable  investigative measures, to the extent of the Company's limited
financial resources and management expertise.

 The manner in which each Company  participates in an opportunity will depend on
the nature of the  opportunity,  the respective needs and desires of the Company
and  other  parties,  the  management  of  the  opportunity,  and  the  relative
negotiating strength of the Company and such other management.

 With respect to any mergers or acquisitions,  negotiations  with target company
management  will be expected  to focus on the  percentage  of the Company  which
target company shareholders would acquire in exchange for their shareholdings in
the target company.  Depending upon,  among other things,  the target  company's
assets and liabilities, the Company's shareholders will in all likelihood hold a
lesser  percentage  ownership  interest in the Company  following  any merger or
acquisition. The percentage ownership may be subject to significant reduction in
the event the Company  acquires a target company with  substantial  assets.  Any
merger  or  acquisition  effected  by the  Company  can be  expected  to  have a
significant  dilative  effect on the  percentage of shares held by the Company's
then shareholders, including purchasers in this offering. (See "Risk Factors.")

 The Company will not have sufficient funds (unless it is able to raise funds in
a private  placement) to undertake any  significant  development,  marketing and
manufacturing of any products which may be acquired. Accordingly,  following the
acquisition  of any such  product,  the  Company  will,  in all  likelihood,  be
required to either seek debt or equity  financing  or obtain  funding from third
parties, in exchange for which the Company would probably be required to give up
a  substantial  portion of its  interest in any  acquired  product.  There is no
assurance that the Company will be able either to obtain additional financing or
interest  third  parties  in  providing  funding  for the  further  development,
marketing and manufacturing of any products acquired.

 It is anticipated that the investigation of specific business opportunities and
the  negotiation,  drafting  and  execution of relevant  agreements,  disclosure
documents and other  instruments  will require  substantial  management time and
attention and  substantial  costs for  accountants,  attorneys and others.  If a
decision is made not to participate in a specific business opportunity the costs
therefore  incurred  in the  related  investigation  would  not be  recoverable.
Furthermore, even if an agreement is reached for the participation in a specific
business  opportunity,  the failure to consummate that transaction may result in
the loss of the Company of the related costs incurred.


                                                         5

<PAGE>



 Management  believes  that the Company  may be able to benefit  from the use of
"leverage"  in  the  acquisition  of  a  business   opportunity.   Leveraging  a
transaction involves the acquisition of a business through incurring significant
indebtedness  for a large  percentage of the purchase  price for that  business.
Through a leveraged  transaction,  the Company  would be required to use less of
its available funds for acquiring the business opportunity and, therefore, could
commit those funds to the operations of the business opportunity, to acquisition
of other business  opportunities or to other activities.  The borrowing involved
in a  leveraged  transaction  will  ordinarily  be  secured by the assets of the
business opportunity to be acquired. If the business opportunity acquired is not
able to generate  sufficient  revenues to make  payments on the debt incurred by
the Company to acquire that  business  opportunity,  the lender would be able to
exercise  the  remedies  provided  by  law  or  by  contract.  These  leveraging
techniques,  while  reducing the amount of funds that the Company must commit to
acquiring a business opportunity,  may correspondingly increase the risk of loss
to the Company. No assurance can be given as to the terms or the availability of
financing for any  acquisition  by the Company.  No assurance can be given as to
the terms or the  availability  of financing for any acquisition by the Company.
During  periods  when  interest  rates are  relatively  high,  the  benefits  of
leveraging  are not as great as during  periods of lower  interest rates because
the investment in the business  opportunity  held on a leveraged basis will only
be profitable if it generates  sufficient revenues to cover the related debt and
other costs of the  financing.  Lenders  from which the Company may obtain funds
for  purposes  of a  leveraged  buy-out  may impose  restrictions  on the future
borrowing,  distribution,  and  operating  policies  of the  Company.  It is not
possible at this time to predict the  restrictions,  if any,  which  lenders may
impose or the impact thereof on the Company.

Competition

 The  Company  is an  insignificant  participant  among  firms  which  engage in
business  combinations  with, or financing of,  development  stage  enterprises.
There are many  established  management and financial  consulting  companies and
venture capital firms which have  significantly  greater financial and personnel
resources,  technical  expertise and experience than the Company. In view of the
Company's limited financial resources and management  availability,  the Company
will  continue  to  be a  significant  competitive  disadvantage  vis-a-vis  the
Company's competitors.

Regulation and Taxation

 The Investment Company Act of 1940 defines an "investment company" as an issuer
which is or holds  itself out as being  engaged  primarily  in the  business  of
investing,  reinvesting  or trading of  securities.  While the Company  does not
intend to  engage in such  activities,  the  Company  could  become  subject  to
regulation  under the  Investment  Company  Act of 1940 in the event the Company
obtains or  continues  to hold a minority  interest  in a number of  development
stage   enterprises.   The  Company  could  be  expected  to  incur  significant
registration  and compliance  costs if required to register under the Investment
Company  Act of 1940.  Accordingly,  management  will  continue  to  review  the
Company's  activities  from  time  to  time  with a  view  toward  reducing  the
likelihood the Company could be classified as an "investment company."

 The Company  intend to structure a merger or  acquisition  in such manner as to
minimize  Federal  and state tax  consequences  to the Company and to any target
company.

Employees

 The  Company's  only  employees  at the  present  time  are  its  officers  and
directors,  who will devote as much time as the Board of Directors  determine is
necessary to carry out the affairs of the Company. (See "Management").


                                                         6

<PAGE>



Risk Factors

 Potential  investors  should consider the following  special risk factors which
pertain to the Company.

 New  Company:  No  Revenues  from  Operation;  Risk of Loss.  The  Company  was
incorporated  on June 11,  1992 and  faces all of the  risks  inherent  in a new
business, coupled with the risks involved with a blind pool/blank check company.
Since the  Company is a start-up  venture,  it is without any record of earnings
and sales. There is no information at this time upon which to base an assumption
that its plans will  either  materialize  or prove  successful.  There can be no
assurance  that any of the  Company's  business  activities  will  result in any
operating revenues or profits.  Investors should be aware that they may lose all
or substantially all of their investment.

 Reliance  Upon  Officers;  No  Experience.  The Company is  dependent  upon the
personal  efforts and abilities of its officers and  directors,  who devote only
minimal  time to the affairs of the Company.  The officers and  directors of the
Company  have  certain  business  experience  but  have  limited  experience  in
acquisition or merger activities.  The officers and directors have not agreed to
expend any  specific  amount of time on behalf of the  Company,  but will devote
such time as necessary to identify and consummate a merger or acquisition.  (See
"Management").

 Dilution  on Change in Control.  The Company may acquire or merge with  another
company  through  the  issuance of its Common  Stock or shares of its  preferred
stock which will dilute the existing  shareholders'  percentage  interest in the
Company,  and may, in come instances,  result in the further dilution of the per
share book value of the Company's  Common Stock.  An acquisition may involve the
appointment  of  additional  members  to the  Company's  Board of  Directors  or
resignation  of some or all of the  current  directors,  which  may  result in a
change  of  Management.  Should  any such  acquisition  or  merger  take  place,
investors  in this  offering  will not have the benefit of knowing the  business
backgrounds  of any future  members of the  Company's  Board of  Directors.  The
Company  does not intend to provide  the  Company's  security  holders  with any
disclosure  documents,  including  audited financial  statements,  concerning an
acquisition or merger  candidate and its business prior to the  consummation  of
any merger or acquisition transaction.

 Financing  Required.  The  Company's  ability to operate as a going  concern is
contingent upon its receipt of additional  financing through private  placements
or by loans or capital contributions from officers and directors.  The Company's
business may require  additional funds in the future.  There can be no assurance
that if additional funds are required they will be available,  or, if available,
that they can be obtained on terms satisfactory to Management.  In the event the
Company  elects  to  issue  preferred  stock  to raise  additional  capital  for
acquisition  or merger  purposes,  any  rights or  privileges  attached  to such
preferred stock may either (i) dilute the percentage of ownership of the already
issued  common  shares or (ii)  dilute  the value of such  shares.  No rights or
privileges  have been  assigned to the  preferred  stock and any such rights and
privileges  will be at the total  discretion  of the Board of  Directors  of the
Company.

 Lack of Market for the Common Stock.  At the present  time,  there is no public
market for the  Company's  Common  Stock,  and there can be no assurance  that a
market  will in fact  develop.  Even if a  market  does  develop,  it may not be
sustained.  At present  there are no market makers for the shares of the Company
and the Common Stock of the Company does not trade on any market.

 Leveraged  Transactions.  There  is a  possibility  that any  acquisition  of a
business  opportunity  by the Company may be  leveraged,  i.e.,  the Company may
finance the  acquisition of the business  opportunity by borrowing on the assets
of the business opportunity to be acquired, on the projected future revenues, or
the profitability of the business opportunity. This could increase the Company's
exposure to larger losses. A business  opportunity  acquired through a leveraged
transaction  is  profitable  only if it generates  enough  revenues to cover the
related  debt and  expenses.  Failure to make  payments on the debt  incurred to
purchase the business  opportunity  could result in the loss of a portion or all
of the assets  acquired.  There is no assurance  that any  business  opportunity
acquired through a leveraged  transaction will generate  sufficient  revenues to
cover the related debt and expenses.


                                                         7

<PAGE>



 No Arrangements.  None of the Company's officers,  directors,  promoters, their
affiliates or associates have had any material  contact or discussions  with and
there are no present plans,  proposals,  arrangements or  undertakings  with any
representatives  of  the  owners  of  any  business  or  company  regarding  the
possibility of an acquisition or merger transaction contemplated herein.

 Time to be Devoted by Management. The officers and directors of the Company are
currently  employed in other  positions  and will devote only a portion of their
time (not more than one hour per week) to the  business  affairs of the Company,
until such time as an acquisition has been determined to be highly favorable, at
which  time they  expect to spend full time in  investigating  and  closing  any
acquisition  for a period of two weeks.  In  addition,  in the face of competing
demands for their time,  the officers and directors may grant  priority to their
full-time positions rather than to the Company.

 Type of Business Acquired. The type of business to be acquired may be one which
desires to avoid effecting its own public offering and the accompanying expense,
delays,  and federal and state  requirements which purport to protect investors.
In particular,  business acquired may be one which, due to merit requirements of
state  securities  authorities,  would  not be  permitted  to make a  securities
offering in many states.  Because of the Company's  limited capital,  it is more
likely than not that any  acquisition by the Company that would take place would
involve other parties whose primary  interest is the  acquisition  of a publicly
traded company.

 Blue Sky Compliance.  The trading of securities of blank check companies may be
restricted by the "Blue Sky" laws of the several  states.  With the exception of
solicited  "unsolicited"  transactions,  Management  is aware that  unrestricted
trading of blank check stocks is prohibited in the states of California,  Idaho,
Indiana,  Minnesota,  Michigan,  and Texas,  and may be prohibited in many other
states  absent the  availability  of exemptions  which are in the  discretion of
state securities administrators. The effect of these state laws will be to limit
the trading market, if any, for the shares of the Company and make the resale of
shares acquired by investors more difficult.

 Loss of  Control  by Present  Management  and  Shareholders.  The  Company  may
consider a merger in which the Company issues a substantial amount of its Common
Stock  as   consideration   for  any   acquisition  (70  -  80%  if  a  tax-free
reorganization  is  desired).  The  result  of such a  merger  would be that the
acquired  Company's  shareholders and management would control the Company,  and
the  Company's  management  could be replaced by persons  whose  background  and
competence are unknown at this time.  Such a merger could leave the investors in
this offering with stock worth  substantially  less than the price paid for such
stock in this  offering,  and a greatly  reduced  percentage of ownership of the
Company. The Company acquired may be a privately held company.  Management could
sell its control block of stock to the acquired  company's  shareholders.  There
are no agreements or understandings for any officer or director to resign at the
request of another  person and none of the officers or  directors  are acting on
behalf of or will act at the direction of any other person.  See "Acquisition of
Opportunities."

 Lack of Dividends.  The Company has no paid dividends and does not  contemplate
paying  dividends in the  foreseeable  future.  There is no assurance  that if a
merger or acquisition occurs, the surviving company will pay any dividends.

 Substantial  Management  Conflicts.  Certain  conflicts  of interest  may exist
between the Company and its management, and conflicts may develop in the future.
The officers and directors of the Company hold similar  positions  with Hermaton
Company,  a company engaged in the same business as the Company.  In the event a
business  opportunity  is  presented  to the  management,  they will present the
opportunity to the Company before the Hermaton  Company,  until such time as the
Company has entered into an  acquisition or a merger  transaction.  The officers
and  directors  intend  to  become  involved  with  several  other  blank  check
companies, and a similar conflict policy will be adopted.

 Possible Rule 144 Sales. All of the 400,000 shares of the Company's outstanding
Common Stock are "restricted securities" and may be sold only in compliance with
Rule 144 adopted under the Securities Act of 1933 or other applicable exemptions
from  registration.  Rule 144 provides that a person affiliated with the Company
and holding restricted  securities for a period of two years may thereafter sell
in brokerage transactions, an amount not

                                                         8

<PAGE>



exceeding  in any  three  month  period  the  greater  of  either  (i) 1% of the
Company's  outstanding  Common Stock,  or (ii) the average weekly trading volume
during a period of four calendar weeks immediately  preceding any sale.  Persons
who are not  affiliated  with the  Company  and who have held  their  restricted
securities  for at least three  years are not subject to the volume  limitation.
Possible or actual sales of the Company's  Common Stock by present  shareholders
under Rule 144, which could occur as early as May 4, 1994, may have a depressive
effect  on the  price of the  Company's  Common  Stock in any  market  which may
develop.

 Inability to Conduct  Extensive  Analysis.  Because of its limited  funds,  the
Company will unable to conduct extensive  analysis of any prospective  merger or
acquisition.  As a result,  any decisions made by management may be made without
the benefit of exhaustive  studies and analysis  which might be available if the
Company had more money for  analysis.  If the funds  allotted by the Company are
depleted  before an  acquisition  or merger is completed,  the Company will have
exhausted its capital and may not be able to continue operations.

 Risks of Low Priced Stocks. Trading, if any, in the Common Stock will likely be
conducted in the over-the-counter  market in the so-called "pink sheets," or the
NASD's "Electronic Bulletin Board." Consequently, a shareholder may find it more
difficult to dispose of, or to obtain  accurate  quotations  as to the price of,
the Company's securities.

 In the absence of a security  being  quoted on NASDAQ,  or the  Company  having
$2,000,000  in net  tangible  assets,  trading in the Common Stock is covered by
Rule 15c2-6 promulgated under the Securities Exchange Act of 1934 for non-NASDAQ
and  non-exchange  listed  securities.   Under  such  rule,  broker/dealers  who
recommend  such  securities  to persons  other than  established  customers  and
accredited investors (generally institutions with assets in excess of $5,000,000
or  individuals  with a net worth in excess of  $1,000,000  or an annual  income
exceeding  $200,000 or $300,000  jointly with their  spouse) must make a special
written suitability  determination for the purchaser and receive the purchaser's
written  agreement to a transaction  prior to sale.  Securities  are also exempt
from this rule if the market price is at least $5.00 per share, or for warrants,
if the warrants have an exercise price of at least $5.00 per share.

 The  Securities  Enforcement  and  Penny  Stock  Reform  Act of  1990  requires
additional  disclosure  related to the market for penny stocks and for trades in
any  stock  defined  as a penny  stock.  The  Commission  has  recently  adopted
regulations  under  such Act  which  define a penny  stock to be any  NASDAQ  or
non-NASDAQ  equity  security  that has a market price or exercise  price of less
than  $5.00 per share and allow for the  enforcement  against  violators  of the
proposed  rules.  In addition,  unless  exempt,  the rules require the delivery,
prior to any  transaction  involving a penny  stock,  of a  disclosure  schedule
prepared by the Commission  explaining  important  concepts  involving the penny
stock  market,  the  nature  of such  market,  terms  used in such  market,  the
broker/dealer's  duties  to the  customer,  a  toll-free  telephone  number  for
inquiries about the  broker/dealer's  disciplinary  history,  and the customer's
rights and remedies in case of fraud or abuse in the sale.  Disclosure also must
be made about  commissions  payable to both the broker/dealer and the registered
representative,  current quotations for the securities, and if the broker/dealer
is the sole  market-maker,  the  broker/dealer  must  disclose this fact and its
control over the market.  Finally,  monthly  statements  must be sent disclosing
recent price information for the penny stock held in the account and information
on the limited market in penny stocks.

 While many NASDAQ stocks are covered by the proposed definition of penny stock,
transactions  in NASDAQ  stock  are  exempt  from all but the sole  market-maker
provision for (i) issuers who have $2,000,000 in tangible assets  ($5,000,000 if
the  issuer  has  not  been in  continuous  operation  for  three  years),  (ii)
transactions in which the customer is an institutional  accredited  investor and
(iii) transactions that are not recommended by the  broker/dealer.  In addition,
transactions in a NASDAQ security directly with the NASDAQ market-maker for such
securities,  are  subject  only to the  sole  market-maker  disclosure,  and the
disclosure  with regard to commissions to be paid to the  broker/dealer  and the
registered representatives.

 Finally, all NASDAQ securities are exempt if NASDAQ raised its requirements for
continued  listing so that any issuer with less than  $2,000,000 in net tangible
assets or stockholder's equity would be subject to delisting. These criteria are
more stringent than the proposed increased in NASDAQ's maintenance requirements.

                                                         9

<PAGE>




 The Company's securities are subject to the above rules on penny stocks and the
market  liquidity for the  Company's  securities  could be severely  affected by
limiting the ability of broker/dealers to sell the Company's securities.

 Preferred  Shares.  The Board of Directors has total discretion in the issuance
and the  determination  of the rights and  privileges of any shares of Preferred
Stock or  Common  Stock  which may be issued in the  future,  which  rights  and
privileges may be detrimental to the holders of the Common Stock of the Company.
The Company is authorized to issue 1,000,000  shares of its Preferred Stock, par
value $.001 and a total of 20,000,000  shares of Common Stock. (See "Description
of Securities").

Item 2.   DESCRIPTION OF PROPERTY

 The Company rents an executive  suite on an as needed  basis.  The Company pays
its own  charges  for long  distance  telephone  calls and  other  miscellaneous
secretarial, photocopying and similar expenses.

Item 3.   LEGAL PROCEEDINGS

 Not Applicable.

Item 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 No matters  were  submitted  to a vote of  security  holders  during the fourth
quarter of the fiscal year ended March 31, 1995.

                                                        10

<PAGE>



                                                      PART II


Item 5.   MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER
          MATTERS

         The Company's Common Stock has not traded.  As of March 31, 1995, there
 were 110 stockholders of
record.

Item 6.      MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

Selected Financial Information

             The following sets forth selected financial information as of March
31, 1993 and 1994, and is qualified in its entirety by the financial  statements
appearing  elsewhere in this Annual  Report.  The  Company's  fiscal year end is
March 31st.
<TABLE>
<CAPTION>

                                                Balance Sheet Data
                                                      March 31,          March 31,       March 31,
                                                         1995               1994            1993

<S>                                                   <C>              <C>              <C>          
Cash         ......................................   $                 $               $     214
Organizational Costs...............................                           177             234
Total Assets.                                                                 177             448
Total Liabilities..................................                            60             220
Stockholders' Equity...............................                           117             228
</TABLE>

        The  Company  has  been  recently  formed  and  has not  engaged  in any
operations other than  organizational  matters.  Its operating  deficit is being
founded by an officer and director.

Item 7.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

            The consolidated  financial statements of the Company required to be
            included in Item 7 are set forth in the Financial  Statements Index.
            Its operating deficient is being funded by an officer and director.

Item 8.     CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
            FINANCIAL DISCLOSURE

            Not Applicable.

                                                        11

<PAGE>



                                                     PART III

Item 9.     DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
            COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT.

Directors and Executive Officers

            The members of the Board of Directors of the Company serve until the
next  annual  meeting  of  stockholders,  or until  their  successors  have been
elected.  The  officers  serve  at the  pleasure  of  the  Board  of  Directors.
Information  as to the  directors  and  executive  officers of the Company is as
follows.  The officer and director holds similar  positions in a number of other
"blind pool-blank check" companies. See "Conflicts of Interest."

            Jehu Hand has been  President and Secretary of the Company since its
inception and Chief  financial  Officer since January 1, 1995. Mr. Hand has been
engaged in corporate and  securities  law practice and has been a partner of the
law firm of Hand & Hand since 1992.  From January  1992 to December  1992 he was
the Vice President-Corporate  Counsel and Secretary of Laser Medical Technology,
Inc.,  which designs,  manufactures  and markets  dental lasers and  endodontics
equipment.  He was a director of Laser  Medical from  February  1992 to February
1993.  From January to October,  1992 Mr. Hand was Of Counsel to the Law Firm of
Lewis, D'Amato,  Brisbois & Bisgaard. From January 1991 to January 1992 he was a
shareholder of McKittrick,  Jackson,  DeMarco & Peckenpaugh,  a law corporation.
From January to December 1990 he was a partner of Day,  Campbell & Hand, and was
an associate of its  predecessor  law firm from July 1986 to December 1989. From
1984 to June 1986 Mr. Hand was an associate attorney with Schwartz, Kelm, Warren
&  Rubenstein  in  Columbus,  Ohio.  Jehu  Hand  received  a J.D.  from New York
University School of Law and a B.A. from Brigham Young University.

Conflicts of Interest

            Certain  conflicts of interest now exist and will  continue to exist
between the Company and its officers and directors due to the fact that each has
other business interests to which he devotes his primary attention. Each officer
and director may continue to do so notwithstanding the fact that management time
should be devoted to the business of the Company.

            Certain  conflicts of interest may exist between the Company and its
management,  and conflicts may develop in the future. The officers and directors
of  the  Company  hold  similar   positions  with  Hermaton   Company;   Achiote
Corporation; Helsinki Capital Partners, Inc.; Keratoplanetes Corporation; Quasar
Projects Company, and Vendalux Corporation, and several other similar companies,
all  companies  engaged  in the same  business  as the  Company.  In the event a
business  opportunity  is  presented  to the  management,  they will present the
opportunity  to the Company and to these  companies  in the  foregoing  order of
priority,  until such time as each company has entered into an  acquisition or a
merger transaction.  The officers and directors may become involved with several
other blank check companies, and a similar conflict policy will be adopted.

            The  Company has not  established  policies  or  procedures  for the
resolution of current or potential  conflicts of interests  between the Company,
its officers and  directors or  affiliated  entities.  There can be no assurance
that  management will resolve all conflicts of interest in favor of the Company,
and failure by  management  to conduct the  Company's  business in the Company's
best  interest  may result in  liability  to the  management.  The  officers and
directors are accountable to the Company as  fiduciaries,  which means that they
are required to exercise  good faith and  integrity  in handling  the  Company's
affairs. Shareholders who believe that the Company has been harmed by failure of
an officer or director to  appropriately  resolve any conflict of interest  may,
subject to applicable rules of civil procedure,  be able to bring a class action
or derivative suit to enforce their rights and the Company's rights.

            The Company has no arrangement,  understanding or intention to enter
into any  transaction for  participating  in any business  opportunity  with any
officer,  director,  or  principal  shareholder  or with  any  firm or  business
organization with which such persons are affiliated,  whether by reason of stock
ownership, position as an officer or director, or otherwise.


                                                        12

<PAGE>



            The  Company,   by   resolution   of  its  Board  of  Directors  and
stockholders,  adopted a 1992 Stock  Option Plan (the  "Plan") on June 11, 1992.
The Plan enables the Company to offer an incentive based compensation  system to
employees,  officers and directors and to employees of companies who do business
with the Company.

            In the discretion of a committee comprised of non-employee directors
(the "Committee"), directors, officers, and key employees of the Company and its
subsidiaries  or  employees of  companies  with which the Company does  business
become  participants  in the Plan  upon  receiving  grants  in the form of stock
options or restricted  stock.  A total of 2,000,000  shares are  authorized  for
issuance  under the Plan,  of which  20,000  shares are issuable  under  options
granted to an officer  and  director  at $.50 per share,  and 20,000  shares are
issuable to the same individual at $.01 per share, both exercisable until May 4,
1997. The Company does not intend to grant additional options until such time as
a merger or  acquisition  has been  consummated.  The Company may  increase  the
number of  shares  authorized  for  issuance  under  the Plan or may make  other
material  modifications to the Plan without  shareholder  approval.  However, no
amendment may change the existing rights of any option holder.

            Any shares  which are  subject to an award but are not used  because
the terms and  conditions of the award are not met, or any shares which are used
by participants to pay all or part of the purchase price of any option may again
be used for awards under the Plan. However, shares with respect to which a stock
appreciation right has been exercised may not again be made subject to an award.

            Stock  options  may be granted  as  non-qualified  stock  options or
incentive  stock  options,  but incentive  stock options may not be granted at a
price  less  than 100% of the fair  market  value of the stock as of the date of
grant (110% as to any 10% shareholder at the time of grant); non-qualified stock
options may not be granted at a price less than 85% of fair market  value of the
stock as of the date of grant.  Restricted  stock may not be  granted  under the
Plan in connection with incentive stock options.

            Stock options may be exercised  during a period of time fixed by the
Committee except that no stock option may be exercised more than ten years after
the date of grant or three years after death or disability,  whichever is later.
In the discretion of the Committee, payment of the purchase price for the shares
of stock  acquired  through the  exercise of a stock option may be made in cash,
shares of the Company's Common Stock or by delivery or recourse promissory notes
or a combination  of notes,  cash and shares of the Company's  common stock or a
combination  thereof.  Incentive  stock options may only be issued to directors,
officers and employees of the Company.

            Stock options may be granted under the Plan may include the right to
acquire an Accelerated Ownership Non-Qualified Stock Option ("AO"). If an option
grant  contains  the AO  feature  and if a  participant  pays all or part of the
purchase  price of the option with shares of the Company's  common  stock,  then
upon exercise of the option the participant is granted an AO to purchase, at the
fair market value as of the date of the AO grant, the number of shares of common
stock the  Company  equal to the sum of the number of whole  shares  used by the
participant in payment of the purchase price and the number of whole shares,  if
any,  withheld  by the Company as payment for  withholding  taxes.  An AO may be
exercised  between the date of grant and the date of  expiration,  which will be
the same as the date of expiration of the option to which the AO is related.

            Stock appreciation  rights and/or restricted stock may be granted in
conjunction  with, or may be unrelated to stock  options.  A stock  appreciation
right entitles a participant to receive a payment,  in cash or common stock or a
combination  thereof,  in an amount equal to the excess of the fair market value
of the stock at the time of exercise  over the fair market  value as of the date
of grant.  Stock  appreciation  rights may be exercised  during a period of time
fixed by the  Committee not to exceed ten years after the date of grant or three
years after death or disability,  whichever is later.  Restricted stock requires
the  recipient  to  continue  in service as an  officer,  director,  employee or
consultant  for a fixed period of time for  ownership of the shares to vest.  If
restricted  shares or stock  appreciation  rights  are  issued  in  tandem  with
options,  the  restricted  stock or stock  appreciation  right is canceled  upon
exercise of the option and the option will  likewise  terminate  upon vesting of
the restricted shares.


                                                        13

<PAGE>



Item 10. EXECUTIVE COMPENSATION

            No  compensation  is paid or  anticipated  to be paid by the Company
until an acquisition is made.

            On acquisition  of a business  opportunity,  current  management may
resign and be  replaced  by persons  associated  with the  business  opportunity
acquired,  particularly if the Company participates in a business opportunity by
effecting a reorganization,  merger or  consolidation.  If any member of current
management  remains after  effecting a business  opportunity  acquisition,  that
member's time  commitment will likely be adjusted based on the nature and method
of the  acquisition  and  location of the business  which  cannot be  predicted.
Compensation of management will be determined by the new board of directors, and
shareholders  of the Company will not have the opportunity to vote on or approve
such compensation.

            Directors  currently  receive no  compensation  for their  duties as
directors.

Item 11.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

           The following table sets forth information relating to the beneficial
ownership of Company  common stock by those  persons  beneficially  holding more
than 5% of the Company capital stock,  by the Company's  directors and executive
officers,  and by all of the Company's  directors  and  executive  officers as a
group, as of March 31, 1995.
<TABLE>
<CAPTION>

                                                                                   Percentage
               Name of                           Number of                       of Outstanding
             Stockholder                       Shares Owned                       Common Stock

<S>                   <C>                           <C>                               <C>  
            Jehu Hand (1)(2)                        285,500                           46.0%

            Elizabeth Rodelli                        90,000                           21.2%
            2249 Via Salvador
            San Clemente, CA 92672

            All officers and
            directors as a group
            (1 person) (1)                          285,500                           46.0%
</TABLE>

         (1)      Includes 40,000 shares issuable upon exercise of stock options
 held by Mr. Hand, and 155,500
                  Shares of common stock issuable upon conversion of a
 promissory note.
         (2)      The address of such person is care of the Company.


                                                        14

<PAGE>



Item 12.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

         In connection  with organizing the Company,  persons  consisting of its
officers,  directors, and other individuals paid an aggregate of $500 in cash to
purchase a total of 400,000  shares of Common Stock at an average sales price of
$.00125 per share.  In April 1993  Messrs.  Hand and Anderson  also  contributed
$500.00 to the Company as a contribution to capital.  Under Rule 405 promulgated
under the Securities Act of 1933, Messrs.  Hand and Anderson may be deemed to be
promoters of the Company.  No other persons are known to Management  which would
be deemed to be promoters.

         An officer of the Corporation has advanced  certain  expenses on behalf
of the Company.  As of March 31, 1995 such expenses  totalled $1,558 the Company
has given the officer a demand  promissory note  convertible into 155,500 shares
of common stock at the officer's option.


                                                        15

<PAGE>



                                                      PART IV


Item 13.    EXHIBITS AND REPORTS ON FORM 8-K

            (a) Exhibits.  The following exhibits of the Company are included
 herein.

                                                             
    Exhibit No.            Document Description  

        3.                 Certificate of Incorporation and Bylaws

                           3.1.     Articles of Incorporation(1)
                           3.2      Bylaws(1)

         10.               Material Contracts

                           10.1.    1992 Stock Option Plan(1)
                           10.2     Stock Option Agreement with Jehu Hand(1)
                           10.3     Stock Option Agreement with Eric Anderson(1)
                           10.4     Stock Option Agreement with Jehu Hand(2)
                           10.5     Demand Convertible Promissory Note from Jehu
 Hand(2)

(1)      Incorporated by reference to such exhibit as filed with the Company's
 registration statement on Form 10-SB,
         File No. 0-24368.
(2)      Filed herewith.

        (b)                Reports on Form 8-K.

                           Not Applicable.


                                                        16

<PAGE>



Board of Directors of
NANOTECH CORPORATION

                                           INDEPENDENT AUDITOR'S REPORT

I have  audited the  statement  of financial  position of  Picometrix,  Inc. ( a
development  stage  company)  as of March  31,  1994 and 1993,  and the  related
statements of operations, changes in stockholders' equity and cash flows for the
year ended March 31, 1994 and from  inception  (June 11, 1992) through March 31,
1993.

I conducted my audit in accordance with generally  accepted auditing  standards.
Those standards  require that I plan and perform the audit to obtain  reasonable
assurance   about  whether  the  financial   statements  are  free  of  material
misstatements. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
I believe that my audit provides a reasonable basis for my opinion.

In my opinion, the financial statements referred to above present fairly, in all
material  respects,  the financial  position of Picometrix,  Inc. (a development
stage company) as of March 31, 1994 and 1993, and the results of its operations,
changes in stockholders' equity and cash flows for the year ended March 31, 1994
and from  inception  (June 11, 1992) through March 31, 1993, in conformity  with
generally accepted accounting principles.




Terrence J. Dunne
Certified Public Accountant

Spokane, Washington
May 26, 1994

                                                        17

<PAGE>
<TABLE>
<CAPTION>


NANOTECH CORPORATION
(A Development Stage Company)                                                      Statements of Financial Position


                                                      ASSETS

                                                                 March 31,          March 31,        March 31,
                                                                   1995               1994             1993
                                                                (unaudited)

<S>                                                              <C>                <C>              <C>      
CURRENT ASSETS - CASH                                            $                  $    746         $     220
     OTHER ASSETS
            Organization costs, net of accumulated
            amortization of $161, $105 and $42 (Note 1)                126               182               238

     TOTAL ASSETS                                                $     126          $    928         $     458



                                       LIABILITIES AND STOCKHOLDERS' EQUITY



CURRENT LIABILITIES - Accounts payable                           $   1,555          $    168         $     220

STOCKHOLDERS' EQUITY
Preferred Stock, $.001 par value; 1,000,000 shares
  authorized; no shares issued and outstanding                                           -0-

Common Stock, $.001 par value; 20,000,000 shares
  authorized; 424,600 and 400,000 shares issued and outstanding425               425              400

Additional paid-in Capital                                             821               821               100

Accumulated deficit during the development stage                   (2,675)             (486)             (262)


     TOTAL STOCKHOLDERS' EQUITY                                    (1,429)               760               238



TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY                       $     126          $    928         $     458



</TABLE>







                     The  accompanying   notes  are  an  integral  part  of  the
financial statements.

                                                        18

<PAGE>

<TABLE>
<CAPTION>


NANOTECH CORPORATION
(A Development Stage Company)                                                              Statements of Operations



                                                                                      FOR THE        CUMULATIVE
                                                                                    FISCAL YEAR         FROM
                                          FOR THE               FOR THE           FROM INCEPTION      INCEPTION
                                        YEAR ENDED            YEAR ENDED          (June 11, 1992)  (June 11, 1992)
                                            TO                    TO                    TO               TO
                                       March 31, 1995        March 31, 1994       March 31, 1993   March 31, 1995
                                        (unaudited)                                                  (unaudited)

<S>                                     <C>                  <C>               <C>                <C>        
REVENUES                                $                     $          -0-     $           -0-   $          -0-

OPERATING EXPENSES

    General and Administrative                  2,133                    168                 220            2,521
    Amortization                                   56                     56                  42              154
TOTAL OPERATING EXPENSES                        2,184                    224                 262            2,675


NET (LOSS)                              $     (2,184)         $        (224)     $         (262)   $      (2,675)

NET (LOSS) PER SHARE                    $       (.01)         $        (Nil)     $         (Nil)


WEIGHTED AVERAGE NUMBER
 OF SHARES OUTSTANDING                        424,600                412,300             406,709

</TABLE>




















                     The  accompanying   notes  are  an  integral  part  of  the
financial statements.

                                                        19

<PAGE>

<TABLE>
<CAPTION>


NANOTECH CORPORATION                                                                           Statement of Changes in Stockholders'
(A Development Stage Company)                                                              Equity From Inception (June 11, 1992)
                                                                                                          Through March 31, 1995



                                                                                                    Accumulated
                                                                                                      Deficit
                                                        Common Stock              Additional        During the
                                                                                    Paid-In         Development
                                                  Shares            Amount          Capital            Stage           Total

<S>                                               <C>            <C>             <C>               <C>              <C>    
Issuance of common stock
    for cash                                       400,000       $        400    $        100       $               $       500

Net (loss)                                                                                                (262)           (262)

Balances at
    March 31, 1993                                 400,000                400             100             (262)             238

Net (loss)                                                                                                (224)           (224)

Contribution to capital                                                                   500                               500

Sale of shares in private placement                 24,600                 25             221                               246
 on September 30, 1993

Balances at
    March 31, 1994                                 424,600       $        425    $        821       $     (486)     $       760

Net (loss) (unaudited)                                                                                  (2,189)         (2,189)

Balances at
  March 31, 1995 (unaudited)                       424,600       $        425    $        821       $   (2,675)     $   (1,429)



</TABLE>














                           The accompanying  notes are an integral part of these
financial statements.

                                                               20

<PAGE>
<TABLE>
<CAPTION>



NANOTECH CORPORATION
(A Development Stage Company)                                                                           Statements of Cash Flows



                                                                                       FOR THE
                                                                                     FISCAL YEAR            CUMULATIVE
                                                FOR THE             FOR THE        FROM INCEPTION         FROM INCEPTION
                                                 YEAR                YEAR          (June 11, 1992)         June 11, 1992
                                                 ENDED                TO                 TO                     TO
                                            March 31, 1995      March 31, 1994     March 31, 1993         March 31, 1995


CASH FLOWS FROM OPERATING ACTIVITIES

<S>                                          <C>                 <C>                <C>                    <C>          
    Net (Loss)                               $     (2,189)       $      (224)       $      (262)           $     (2,675)

    Add item not requiring the use
      of cash - amortization                            56                 56                 42                     154

    Increase (decrease) in accounts payable          1,387               (52)                220                   1,555

    Net cash flows from operating activities         (746)              (220)                                      (966)

CASH FLOWS FROM INVESTING ACTIVITIES
    Organization Costs                                                                     (280)                   (280)

CASH FLOWS FROM FINANCING ACTIVITIES
    Contribution to Capital                                               500                                        500
    Sale of common stock                                                  246                500                     746
    Net Cash flows from financing activities                              746                500                   1,246


NET INCREASE IN CASH                                 (746)                529                220

CASH BALANCE AT BEGINNING OF PERIOD                    746                220

CASH BALANCE AT END OF PERIOD                $                   $        746       $        220           $



</TABLE>










                            The  accompanying  notes are an integral part of the

financial statements.

                                                               21

<PAGE>



NANOTECH CORPORATION
(A Development Stage Company)                    Notes to Financial Statements

NOTE 1      ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

            The Company was incorporated under the laws of the State of Delaware
            on  June  11,  1992,   for  the  purpose  of  seeking  out  business
            opportunities,   including  acquisitions.  The  Company  is  in  the
            development stage and will be very dependent on the skills, talents,
            and abilities of management to  successfully  implement its business
            plan.  Due to the Company's  lack of capital,  it is likely that the
            Company will not be able to compete with larger and more experienced
            entities  for  business  opportunities  which are lower risk and are
            more attractive for such entities.  Business  opportunities in which
            the  Company  may  participate  will  likely  be  highly  risky  and
            speculative.  Since  inception,  the Company's  activities have been
            limited  to  organizational   matters.   Organizational   costs  are
            amortized on a straight-line basis over five years.

            The financial statements as of and for the year ended March 31, 1995
            are  unaudited,  pursuant to the exemption  provided by Rule 3-12 of
            Regulation S-X.

NOTE 2      CASH AND CASH EQUIVALENTS

            The Company  considers all short-term  investments  with an original
            maturity of three months or less to be cash equivalents.


NOTE 3      RELATED PARTY TRANSACTIONS

            The  Company  currently  receives  the use of office  space  free of
            charge from Jehu Hand,  president  of the  Company.  The fair market
            value of the office space in the same  geographic  region is $20 per
            month.

            The officers and  directors of the Company  currently  serve without
compensation.

            An officer of the  Corporation  has  advanced  certain  expenses  on
            behalf of the Company.  As of March 31, 1995 such expenses  totalled
            $1,555.  The Company has given the officer a demand  promissory note
            convertible  into 155,500  shares of common  stock at the  officer's
            option.


NOTE 4      INCOME TAXES

            The fiscal  year end of the  Company is March 31st and an income tax
            return has not been filed. However, if an income tax return had been
            filed,  the Company would have a net operating loss  carryforward of
            $486 that would begin expiring in the year 2008.


NOTE 5      STOCK OPTION PLAN

            The  Company  has  stock  option  plans  for  directors,   officers,
            employees,  advisors,  and  employees of companies  that do business
            with the Company,  which  provide for  non-qualified  and  qualified
            stock options.  The Stock Option  Committee of the Board  determines
            the option  price which cannot be less than the fair market value at
            the  date of the  grant  of 110% of the  fair  market  value  if the
            Optionee holds 10% or more of the Company's  common stock. The price
            per share of share  subject to a  Non-Qualified  Option shall not be
            less  than 85% of the fair  market  value at the date of the  grant.
            Options  generally  expire either three months after  termination of
            employment,  or ten years  after  date of grant  (five  years if the
            optionee holds 10% or more of the Company's common stock at the time
            of grant).

                                                        22

<PAGE>



NANOTECH CORPORATION
(A Development Stage Company)                    Notes to Financial Statements

Options outstanding:
            Shares allocated                             2,000,000

                 Option price                       $          .50

            Balance at inception                                --
            Granted                                         40,000
            Balance outstanding at
            March 31, 1993                                  40,000
            Granted                                             --
            Balance outstanding at
            March 31, 1994                                  40,000

            Granted                                         20,000
            Lapsed                                          20,000

            Balance Outstanding at
            March 31, 1995                                  40,000


            Year exercisable:
                 1997                                       40,000







                                                        23

<PAGE>


                                                    SIGNATURES

        Pursuant to the  requirements  of Section 13 or 15(d) of the  Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized April 10, 1995.


                                                           NANOTECH CORPORATION


                                                           By:    /s/ Jehu Hand
                                                                  Jehu Hand
                                                                  President

        Pursuant to the  requirements  of the  Securities  Exchange Act of 1934,
this  report has been  signed  below by the  following  persons on behalf of the
Registrant and in the capacities on April 10, 1995.



By:     /s/ Jehu Hand                                President, Secretary, Chief
                                               Financial Officer and Director
        Jehu Hand

                                                        24

<PAGE>


                                 1992 STOCK OPTION PLAN OF NANOTECH CORPORATION


                                          STOCK OPTION AGREEMENT



         This Stock Option  Agreement (the  "Agreement")  is made by and between
Picometrix,  Inc., a Delaware  corporation (the  "Company"),  and Jehu Hand (the
"Optionee") as of the date set forth on the signature page hereto.

                                                  R E C I T A L S

         A. The Board of Directors of the Company (the "Board") has  established
the 1992 Stock  Option  Plan of the  Company  (the  "Plan"),  for the purpose of
providing to Employees and Directors of the Company and others an opportunity to
acquire shares of the Company's $.001 par value common stock (the "Shares"); and

         B.  The  Board  of  Directors  or the  Stock  Option  Committee  of the
Company's Board of Directors (the "Committee")  appointed to administer the Plan
has  determined  that it would be to the  advantage  and  best  interest  of the
Company and its shareholders to grant the non-qualified stock option,  Incentive
stock option or restricted stock grant provided for herein (the "Option") to the
Optionee  as an  inducement  to remain in the  service of the  Company and as an
Incentive for Increased efforts during such service, and has advised the Company
thereof and instructed it to issue the Option.

                                                 A G R E E M E N T

         NOW,  THEREFORE,  in consideration  of the mutual  covenants  contained
herein and other  good and  valuable  consideration,  receipt of which is hereby
acknowledged, the parties hereto do hereby agree as follows:

                                                     ARTICLE I

                                                    DEFINITIONS

         Whenever the  following  terms are used in this  Agreement,  they shall
have the meaning  specified  below unless the context  clearly  indicates to the
contrary. Capitalized terms used herein and not otherwise defined shall have the
meaning set forth in the Plan. The masculine  pronoun shall Include the feminine
and neuter, and the singular the plural, where the context so indicates.

Section 1.1 - Code

         "Code" shall mean the Internal Revenue Code of 1986, as amended.

Section 1.2 - Company

         "Company"  shall mean  Picometrix,  Inc.. In addition,  "Company" shall
mean any  corporation  assuming,  or  issuing  new  employee  stock  options  in
substitution  for the Option and Incentive  Stock Options (as defined in Section
1.7 of the Plan),  outstanding under the Plan, in a transaction to which Section
425(a) of the Code applies.

Section 1.3 - Option

         "Option" shall mean the option to purchase $.001 par value common stock
of the Company granted under this Agreement.



<PAGE>



Section 1.4 - Plan

         "Plan" shall mean the 1992 Stock Option Plan of the Company.

Section 1.5 - Secretary

         "Secretary" shall mean the Secretary of the Company.

Section 1.6 - Securities Act

         "Securities Act" shall mean the Securities Act of 1933, as amended.

                                                    ARTICLE II

                                                  GRANT OF OPTION

Section 2.1 - Grant of Option

         In  consideration  of the Optionee's  agreement to render  faithful and
efficient services to the Company and for other good and valuable consideration,
on the date set forth on the  Signature  Page hereof (the "Date of Grant"),  the
Company  irrevocably  grants to the  Optionee the option to purchase any part or
all of an  aggregate  of the  number of Shares set forth on the  Signature  Page
hereof and upon the terms and conditions set forth in this Agreement.

Section 2.2 - Purchase Price

         The  purchase  price of the Shares  covered by the Option  shall be the
amount set forth on the Signature Page hereof and shall be without commission or
other charge (the "Purchase Price").

Section 2.3 - Reservation of Rights

         Nothing  in the Plan or in this or any  Stock  Option  Agreement  shall
confer upon the  Optionee  any right to continue in the employ of the Company or
any Subsidiary or shall  interfere with or restrict in any way the rights of the
Company and its Subsidiaries,  which are hereby expressly reserved, to discharge
the Optionee at any time for any reason whatsoever, with or without cause.


Section 2.4 - Adjustments in Option

         In the event  that the  outstanding  Shares  subject  to the Option are
changed  into or  exchanged  for a  different  number  or kind of  shares of the
Company or other  securities of the Company by reason of merger,  consolidation,
recapitalization,   reclassification,   stock  split  up,  stock  dividend,   or
combination of shares,  the Committee  shall make an  appropriate  and equitable
adjustment in the number and kind of shares as to which the Option,  or portions
thereof then unexercised, shall be exercisable, to the end that after such event
the  Optionee's  proportionate  interest  shall  be  maintained  as  before  the
occurrence  of such event.  Such  adjustment in the Option shall be made without
change in the total price  applicable to the  unexercised  portion of the Option
(except for any change in the aggregate  price  resulting from  rounding-off  of
share quantities or prices) and with any necessary  corresponding  adjustment in
the Purchase Price. Any such adjustment made by the Committee shall be final and
binding  upon  the  Optionee,  the  Company,  the  Subsidiaries  and  all  other
interested persons.


                                                         2

<PAGE>




                                                    ARTICLE III

                                             PERIOD OF EXERCISABILITY

Section 3.1 - Commencement of Exercisability

         (a)      The Option shall become exercisable in cumulative installment
 as set forth on the signature page
hereto.

         (b) Excluding Saturdays,  Sundays, and nationally  recognized holidays,
if the Optionee is absent from employment for any reason other than vacation for
an aggregate  period  exceeding sixty (60) days during the annual period between
the Date of Grant and the First  Anniversary Date or any successive  Anniversary
Date and the following  Anniversary Date, then the latter Anniversary Date shall
be postponed by the number of all such days of absence. This paragraph (b) shall
not apply to Optionees who are Directors but not Employees of the Company.

Section 3.2 - Duration of Exercisability

         The installments provided for in Section 3.1 are cumulative.  Each such
installment  which  becomes  exercisable  pursuant to Section  3.1 shall  remain
exercisable  until the  expiration  date set forth on the signature page of this
Agreement or until it becomes unexercisable under the Plan, whichever is sooner.



Section 3.3 - Assumption of Option; Acceleration of Exercisability

         In the event of the merger or consolidation of the Company with or into
another corporation,  or the acquisition by another corporation or person of all
or substantially  all of the Company's assets or eighty percent (80%) or more of
the Company's then  outstanding  voting stock, or the liquidation or dissolution
of the Company, such Option shall be assumed or an equivalent option substituted
by any  successor  corporation  of the Company.  The Company  undertakes to make
reasonable and adequate  provision for such  assumption or  substitution  of the
Option  upon or in  connection  with such  merger,  consolidation,  acquisition,
liquidation, or dissolution.  The Committee may also, in its absolute discretion
and upon such  terms  and  conditions  as it deems  appropriate,  by  resolution
adopted  prior to such event,  provide that at some time prior to the  effective
date of such  event this  Option  shall be  exercisable  as to all of the Shares
covered hereby,  notwithstanding  that this Option may not yet have become fully
exercisable under Section 3.1.

Section 3.4 - Option Not Transferable

         Neither the Option nor any  interest or right  therein or part  thereof
shall be liable for the debts,  contracts, or engagements of the Optionee or his
successors  in  interest  or  shall  be  subject  to  disposition  by  transfer,
alienation,  anticipation,  pledge, encumbrance,  assignment, or any other means
whether such  disposition be voluntary or involuntary or by operation of law, by
judgment,  levy,  attachment,  garnishment  or  any  other  legal  or  equitable
proceedings (Including bankruptcy),  and any attempted disposition thereof shall
be null and void and of no effect;  provided,  however,  that this  Section  3.5
shall not prevent  transfers  by will or by the  applicable  laws of descent and
distribution.



                                                         3

<PAGE>



                                                    ARTICLE IV

                                                EXERCISE OF OPTION

Section 4.1 - Person Eligible to Exercise

         During the  lifetime of the  Optionee,  only he or she may exercise the
Option or any portion thereof.  After the death of the Optionee, any exercisable
portion  of  the  Option  may,  prior  to  the  time  when  the  Option  becomes
unexercisable,  be  exercised by his or her  personal  representative  or by any
person empowered to do so under the Optionee's will or under the then applicable
laws of descent and distribution.

Section 4.2 - Partial Exercise

         Any  exercisable  portion of the Option or the entire  Option,  if then
wholly  exercisable,  may be  exercised in whole or in part at any time prior to
the time when the  Option or portion  thereof  becomes  unexercisable  under the
Plan; provided,  however,  that each partial exercise shall be for not less than
one hundred (100) Shares (or minimum  installment set forth in Section 3.1, if a
smaller number of Shares) and shall be for whole Shares only.

Section 4.3 - Manner of Exercise

         The Option, or any exercisable portion thereof, may be exercised solely
by delivery to the Secretary or the  Secretary's  office of all of the following
prior to the time when the Option or such portion  becomes  unexercisable  under
the Plan:

         (a) Notice in writing  signed by the  Optionee or the other person then
entitled to exercise the Option or portion  thereof,  stating that the Option or
portion thereof is thereby exercised,  such notice complying with all applicable
rules established by the Committee; and

         (b)  (i) Full payment (in cash or by check) for the Shares with respect
 to which such Option or portion
         is exercised; or

             (ii)  Shares  of any  class  of the  Company's  stock  owned by the
         Optionee  duly  endorsed for transfer to the Company with a fair market
         value on the date of delivery  equal to the  aggregate  Option price of
         the Shares  with  respect  to which  such  Option or portion is thereby
         exercised; or

            (iii) With the consent of the Committee,  a full recourse promissory
         note bearing  interest  (at least such rate as shall then  preclude the
         imputation of interest  under the Code or any successor  provision) and
         payable  upon such terms as may be  prescribed  by the  Committee.  The
         Committee may also  prescribe the form of such note and the security to
         be given for such  note.  No  Option  may,  however,  be  exercised  by
         delivery of a  promissory  note or by a loan from the  Company  when or
         where such loan or other extension of credit is prohibited by law; or

             (iv) Any combination of the consideration provided in the foregoing
 subsections (i), (ii), and (iii); and

         (c)      Full payment to the Company of all amounts which, under
federal, state or local law, it is required
to withhold upon exercise of the Option; and

         (d) In the  event the  Option or  portion  thereof  shall be  exercised
pursuant  to  Section  4.1 by any person or  persons  other  than the  Optionee,
appropriate proof of the right of such person or persons to exercise the Option.




                                                         4

<PAGE>



Section 4.4 - Conditions to Issuance of Stock Certificates

         The Shares  deliverable upon the exercise of the Option, or any portion
thereof,  may be either  previously  authorized  but  unissued  Shares or issued
Shares  which have then been  reacquired  by the  Company.  Such Shares shall be
fully paid and  non-assessable.  The  Company  shall not be required to issue or
deliver any certificate or certificates  for Shares  purchased upon the exercise
of the Option or portion  thereof prior to  fulfillment  of all of the following
conditions:

         (a) The completion of any  registration or other  qualification of such
Shares  under any state or federal law or under  rulings or  regulations  of the
Securities and Exchange Commission or of any other governmental regulatory body,
which the  Committee  shall,  in its  absolute  discretion,  deem  necessary  or
advisable;

         (b) The obtaining of any approval or other  clearance from any state or
federal   governmental  agency  which  the  Committee  shall,  in  its  absolute
discretion, determine to be necessary or advisable;

         (c)      The payment to the Company of all amounts which, under
 federal, state, or local law, it is required
to withhold upon exercise of the Option; and

         (d) The lapse of such reasonable  period of time following the exercise
of the Option as the  Committee  may from time to time  establish for reasons of
administrative convenience.

It is understood  that the Shares  deliverable  upon exercise of the Option have
been  registered  under the  Securities  Act, and the Company shall use its best
efforts to keep such registration current.

Section 4.5 - Rights as Stockholder

         The  holder of the  Option  shall not be, nor have any of the rights or
privileges of, a stockholder of the Company in respect of any Shares purchasable
upon the  exercise  of any part of the  Option  unless  and  until  certificates
representing such Shares shall have been issued by the Company to such holder.



                                                     ARTICLE V

                                                 OTHER PROVISIONS

Section 5.1 - Administration

         The  Committee  shall  have the  power to  interpret  the Plan and this
Agreement  and to adopt such rules for the  administration,  interpretation  and
application of the Plan as are  consistent  therewith and to interpret or revoke
any such rules.  All actions taken and all  interpretations  and  determinations
made by the Committee or the Special  Committee in good faith shall be final and
binding  upon  the  Optionee,  the  Company,  the  Subsidiaries  and  all  other
interested persons. No member of the Committee or the Special Committee shall be
personally liable for any action,  determination or interpretation  made in good
faith with respect to the Plan or the Option.  In its absolute  discretion,  the
Board  may at any time and from time to time  exercise  any and all  rights  and
duties of the Committee under the Plan and this Agreement.

Section 5.2 - Shares to Be Reserved

         The Company  shall at all times  during the term of the Option  reserve
and keep  available  such number of Shares as will be  sufficient to satisfy the
requirements of this Agreement.


                                                         5

<PAGE>



Section 5.3 - Notices

         Any notice to be given under the terms of this Agreement to the Company
shall be addressed to the Company in care of its Secretary, and any notice to be
given to the Optionee  shall be addressed to him or her at the address set forth
on the Signature  Page hereof.  By a notice given  pursuant to this Section 5.3,
either  party may  hereafter  designate  a  different  address  for  delivery of
notices.  Any notice which is required to be given to the Optionee shall, if the
Optionee is then deceased, be given to the Optionee's personal representative if
such  representative  has  previously  informed  the  Company  of his status and
address by written  notice  under this  Section  5.3. Any notice shall be deemed
duly given when enclosed in a properly sealed  envelope or wrapper  addressed as
aforesaid and deposited  (with postage  prepaid) in a post office or branch post
office regularly maintained by the United States Postal Service.

Section 5.4 - Titles

         Titles are provided herein for convenience only and are not to serve as
a basis for interpretation or construction of this Agreement.

Section 5.5 - Construction

         This Agreement shall be administered,  interpreted,  and enforced under
the laws of the State of Delaware.

                                                         6

<PAGE>


                                                  SIGNATURE PAGE

                                  1992 STOCK OPTION PLAN OF NANOTECH CORPORATION

           Incentive Stock Option
                         In tandem with stock appreciation right
                         No stock appreciation right

 X         Non-Qualified Option
             X           AO Option
                         In  tandem  with  stock  appreciation  right  No  stock
                         appreciation right In tandem with Restricted Stock
              X          No Restricted Stock

           Restricted stock grant without accompanying option

Purchase Price:           $.01

Number of Shares:         20,000

Vesting:   Immediate as to the entire option.

Expiration:               June 11, 1997

           I have read the Stock  Option  Agreement  indicated  above  which was
adopted for use in connection  with the 1992 Stock Option Plan.  As Optionee,  I
hereby agree to all of the terms of the Agreement.

Date of Grant: March 31, 1995                         Jehu Hand
                                                     ----------
                                  Optionee Name




                                                                   Address

                     Optionee Social Security Number or Taxpayer Identification
                                                     Number:




                                                             Optionee Signature

The Company hereby agrees to all of the terms of the Agreement.

                                NANOTECH CORPORATION


                                                     By:

                                                     Its:

                                                         7

<PAGE>

                                           CONVERTIBLE PROMISSORY NOTE


$1,555                                                        December 31, 1994


         FOR VALUE RECEIVED, the undersigned Nanotech Corporation,  a Delaware
corporation  ("Maker") promises to pay to the order of Jehu Hand ("Lender"),  at
its principal  office, or at such other place as may be designated in writing by
the holders of this Promissory Note ("Note"),  the principal sum of ONE THOUSAND
FIVE HUNDRED  FIFTY-FIVE AND 00/100 DOLLARS  ($1,555.00) (the "Principal  Sum").
The unpaid  Principal Sum shall bear interest from the date hereof until paid at
a rate equal 4% per annum.

         The unpaid  Principal Sum and all accrued but unpaid  interest  thereon
shall all be due and payable on two years of the date of this Note.

         All  payments  to be made  under  this Note  shall be payable in lawful
money of the United States of America which shall be legal tender for public and
private debts at the time of payment.

         In the event that an action is  instituted to collect this Note, or any
portion  thereof,  Maker promises to pay all costs of collection,  including but
not limited to reasonable  attorneys'  fees, court costs, and such other sums as
the court may establish.

         In the event of a default  under this Note when due, then the holder of
this Note, at its election,  may declare the entire unpaid Principal Sum and all
accrued but unpaid interest thereon immediately due and payable.

         Lender  shall have the right at any time to convert the  Principal  Sum
and all accrued and unpaid  interest  thereon  into a number of shares of common
stock of the Maker ("Shares") at a price of $.01 per share.

         Every provision  hereof is intended to be several.  If any provision of
this Note is  determined,  by a court of competent  jurisdiction  to be illegal,
invalid or unenforceable,  such illegality, invalidity or unenforceability shall
not  affect  the  other  provisions  hereof,  which  shall  remain  binding  and
enforceable.

         This Note is made in the State of New Jersey and it is mutually  agreed
that  New  Jersey  law  shall  apply  to the  interpretation  of the  terms  and
conditions of this Note.

         All  agreements  between  the  holder of this Note and Maker are hereby
expressly  limited so that in no  contingency  or event  whatsoever,  whether by
reason of deferment or  acceleration  of the maturity of this Note or otherwise,
shall the rate of  interest  hereunder  exceed  the  maximum  permissible  under
applicable law with


<PAGE>


respect  to the  holder.  If,  from any  circumstances  whatsoever,  the rate of
interest  resulting  from the payment  and/or  accrual of any amount of interest
hereunder,  at any time that  payment of interest is due and/or at any time that
interest is accrued,  shall exceed the limits prescribed by such applicable law,
then the  payment  and/or  accrual  of such  interest  shall be  reduced to that
resulting from the maximum rate of interest  permissible  under such  applicable
law. This provision shall never be superseded or waived.

         The  makers,  endorsers,  and/or  guarantors  of this  Note  do  hereby
severally waive  presentment,  demand,  protest and notices of protest,  demand,
dishonor and nonpayment.

         IN WITNESS  WHEREOF,  this  instrument is executed as of the date first
hereinabove set forth.

                                                       NANOTECH CORPORATION


                                                                             By:
                                                                           Name:
                                                                            Its:





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission